DUBLIN, Jan. 12, 2022 /PRNewswire/ — The "Acute Hospital Care Market Research Report by Medical Condition, by Facility Type, by Service, by Region – Global Forecast to 2027 – Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.
The Global Acute Hospital Care Market size was estimated at USD 229.12 billion in 2020, is expected to reach USD 246.47 billion in 2021, and is projected to grow at a CAGR of 7.93% to reach USD 391.05 billion by 2027.
Market Statistics:
The report provides market sizing and forecast across five major currencies – USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2027 are considered the forecast period.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Acute Hospital Care Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Acute Hospital Care Market, including 3M Company, Asklepios Kliniken GmbH & Co. KGaA, bioMerieux SA, CareCentrix, Inc., Community Health Systems, Inc., Emerus Holdings, Inc., Ernest Health, Inc., Fresenius Medical Care AG & Co, HCA Healthcare, Inc., IHH Healthcare Berhad, Legacy Lifepoint Health, Inc., McKesson Corporation, Mediclinic International PLC, Medline Industries, Inc., National HealthCare Corporation, PruittHealth Corporation, Ramsay Health Care Ltd, Tenet Healthcare Corporation, Universal Health Services, Inc., and Vibra Healthcare, LLC.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Acute Hospital Care Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Acute Hospital Care Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Acute Hospital Care Market?
4. What is the competitive strategic window for opportunities in the Global Acute Hospital Care Market?
5. What are the technology trends and regulatory frameworks in the Global Acute Hospital Care Market?
6. What is the market share of the leading vendors in the Global Acute Hospital Care Market?
7. What modes and strategic moves are considered suitable for entering the Global Acute Hospital Care Market?
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing inpatient volume at hospitals for Acute Care
5.1.1.2. Increasing prevalence of chronic diseases
5.1.1.3. Availability of medicaid and medicare reimbursement
5.1.2. Restraints
5.1.2.1. Limited availability of skilled professionals, facilities and equipment
5.1.3. Opportunities
5.1.3.1. Increasing number of hospital and unmet medical needs in emerging economies
5.1.4. Challenges
5.1.4.1. Dearth in infrastructure
5.2. Cumulative Impact of COVID-19
6. Acute Hospital Care Market, by Medical Condition
6.1. Introduction
6.2. Acute Care Surgery
6.3. Emergency Care
6.4. Short-Term Stabilization
6.5. Trauma Care
7. Acute Hospital Care Market, by Facility Type
7.1. Introduction
7.2. General Acute Care Hospitals
7.3. Long Term Acute Care
7.4. Psychiatric Hospitals
7.5. Rehabilitation Hospitals
7.6. Specialized Hospitals
8. Acute Hospital Care Market, by Service
8.1. Introduction
8.2. Coronary Care Unit
8.3. Intensive Care Unit
8.4. Neonatal Intensive Care Unit
9. Americas Acute Hospital Care Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Acute Hospital Care Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Acute Hospital Care Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. 3M Company
13.2. Asklepios Kliniken GmbH & Co. KGaA
13.3. bioMerieux SA
13.4. CareCentrix, Inc.
13.5. Community Health Systems, Inc.
13.6. Emerus Holdings, Inc.
13.7. Ernest Health, Inc.
13.8. Fresenius Medical Care AG & Co
13.9. HCA Healthcare, Inc.
13.10. IHH Healthcare Berhad
13.11. Legacy Lifepoint Health, Inc.
13.12. McKesson Corporation
13.13. Mediclinic International PLC
13.14. Medline Industries, Inc.
13.15. National HealthCare Corporation
13.16. PruittHealth Corporation
13.17. Ramsay Health Care Ltd
13.18. Tenet Healthcare Corporation
13.19. Universal Health Services, Inc.
13.20. Vibra Healthcare, LLC
14. Appendix
For more information about this report visit https://www.researchandmarkets.com/r/cury97
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
View original content:https://www.prnewswire.com/news-releases/worldwide-acute-hospital-care-industry-to-2027—increasing-number-of-hospital-and-unmet-medical-needs-in-emerging-economies-presents-opportunities-301459391.html
SOURCE Research and Markets
The Oracle of Omaha knows how to beat inflation. So ride his coattails.
ARK Invest went shopping on Wednesday, buying three stocks that are trading 45% to 81% below last year's highs.
While 2021 was very good to Roblox (NYSE: RBLX) shareholders, 2022 is off to an arguably poor start. This gaming platform company with metaverse potential has been caught up in the broader growth stock sell-off and is trading down about 15.7% year to date. Part of the drop can be attributed to some investor concern heading into 2022 about Roblox's rich valuation.
Yahoo Finance's Julie Hyman and Brian Sozzi discuss how Taiwan Semiconductor stock is rising after the company reported Q4 earnings.
These three stocks are yielding between 5.3% and 7.9%, but they are trading at low valuations with strong catalysts to appreciate.
DocuSign (NASDAQ: DOCU) and Adobe (NASDAQ: ADBE) initially seem like very different companies. DocuSign is the world's largest e-signature company, while Adobe provides industry-standard creativity software like Photoshop, Illustrator, and Premiere Pro as cloud-based services. Adobe also integrates those services into its cloud-based sales, marketing, e-commerce, and analytics tools for enterprise customers.
Novavax (NASDAQ: NVAX) has taken investors on quite an exciting ride since it entered the coronavirus vaccine race. Investors expected Novavax to apply for U.S. regulatory authorization in the first half. Novavax has since resolved its production issues and today is on track to apply for U.S. authorization in about a month.
Shares of Chinese electric vehicle maker Nio (NYSE: NIO) were moving lower on Thursday. As of 1:30 p.m. ET, the company's American depositary shares were down about 2.3% from Wednesday's closing price. Nio doesn't own a factory directly; its vehicles are built in a plant owned by a joint venture between it and its manufacturing partner, state-owned automaker Jianghuai Automobile Group.
Retirement is about protecting your nest egg, and living off it. These high-yield dividend stocks can help you.
Shopping for some tech bargains ahead of the Federal Reserve's rate hikes? Try these on for size, says one veteran tech analyst.
Virgin Galactic (SPCE) stock slid 16% on Thursday after announcing a $425 million convertible bond offering.
Shares of Virgin Galactic Holdings (NYSE: SPCE) fell more than 10% at the open on Thursday after the space tourism start-up announced plans to raise up to $500 million in new debt. Virgin Galactic made history last summer when it launched founder Richard Branson into space, but the news has been mostly bad for investors in the months since. A combination of technical glitches and delayed timelines has caused the stock to lose nearly 75% of its value in the last six months, and Virgin Galactic now does not expect to commence regularly scheduled tourist flights until late 2022 at the earliest.
Growth stocks have fallen out of favor, which provides a juicy opportunity to snap up this trio of beauties.
Yahoo Finance’s Julie Hyman and Brian Sozzi discuss short-selling data on Beyond Meat stock after the company announced a partnership with KFC to produce plant-based chicken.
Last month, the diversified healthcare company Abbott Laboratories (NYSE: ABT) raised its quarterly dividend 4.4% from $0.45 to $0.47 per share. Abbott seems to be a thriving business based on its growing sales and profitability.
If investors are willing to forego a high yield today, the following growth stocks look like bargains, and they pay small but growing dividends along the way as a bonus.
AMC Entertainment Chief Executive Adam Aron sold another $7.1 million shares of the movie theater giant this week, and said he’s done selling the stock. “Back in August, I said that at age 67 I’d sell some AMC shares toward year-end, all trading decisions out of my hands, under guidelines of a Chase 10-b-5-1 plan spread over 3 months,” Aron said on Twitter. Aron sold 312,500 shares of AMC Entertainment (ticker: AMC) on Tuesday, according to a regulatory filing.
Shares of chip giant Taiwan Semiconductor Manufacturing (NYSE: TSM), better known as TSMC, were trading higher on Thursday after the company reported earnings that beat estimates. As of 11:30 a.m. ET today, TSMC's shares were up about 6.5% from Wednesday's closing price. Amid an ongoing global shortage of semiconductors, TSMC is going big — really big: The company expects between $40 billion and $44 billion in capital expenditures (capex) this year, upgrading and expanding its manufacturing capacity around the world.
In this article, we discuss the 5 stocks to consider in the latest portfolio of that Nancy Pelosi. If you want to skip our detailed analysis of these stocks, go directly to Nancy Pelosi Latest Portfolio: 2 Stocks to Watch. The stock trading activities of lawmakers on both sides of the aisle have come under […]
In this article, we are going to talk about our list of the 10 undervalued stocks to buy now. You can skip our comprehensive analysis of these stocks and go directly to the 5 Undervalued Stocks to Buy Now. The world is experiencing innovation and change at a rate never seen before. After the Covid […]
